Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00061308
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2003-05-23
Brief Title:
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian Fallopian Or Peritoneal Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-05-23
First Submit QC Date:
May 27 2003
Study First Post Date:
2003-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-08
Last Update Post Date:
2017-06-09
Last Update Post Date Type:
ACTUAL